Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 3284 entries
View as:

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Phase: N/A Priority: Normal
NCT ID: NCT05945108 Org: User:
Start: 07/10/23 End: 04/18/24 Due: 04/18/25

CLL Therapy Approaches in Russia

Phase: N/A Priority: Normal
NCT ID: NCT05140369 Org: User:
Start: 10/29/21 End: 12/31/27 Due: 12/31/28

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043

Phase: N/A Priority: Normal
NCT ID: NCT00918515 Org: User:
Start: 05/31/09 End: 08/31/09 Due: 08/31/10

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

Phase: N/A Priority: Normal
NCT ID: NCT00600756 Org: User:
Start: 01/31/08 End: 10/31/09 Due: 10/31/10

A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT03836677 Org: User:
Start: 02/26/19 End: 11/11/19 Due: 11/11/20

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00082381 Org: User:
Start: 06/30/03 End: 07/31/08 Due: 07/31/09

Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00239304 Org: User:
Start: 06/30/03 End: 03/31/06 Due: 03/31/07

Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01457846 Org: User:
Start: 11/30/11 End: 02/28/15 Due: 02/28/16

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02161757 Org: User:
Start: 06/13/14 End: 07/18/17 Due: 07/18/18

Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03368235 Org: User:
Start: 01/18/18 End: 11/12/19 Due: 11/12/20

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.

Phase: N/A Priority: Normal
NCT ID: NCT01197521 Org: User:
Start: 09/30/10 End: 11/30/12 Due: 11/30/13

GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00300105 Org: User:
Start: 10/31/05 End: 12/31/06 Due: 12/31/07

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329

Phase: N/A Priority: Normal
NCT ID: NCT01207089 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Phase: N/A Priority: Normal
NCT ID: NCT00496470 Org: User:
Start: 05/31/07 End: 06/30/08 Due: 06/30/09

Barrett's Esophagus - 315 - 3 Way Cross-Over

Phase: N/A Priority: Normal
NCT ID: NCT00637559 Org: User:
Start: 03/31/02 End: 04/30/03 Due: 04/30/04

SHARE - Symbicort and Health Economics in a Real Life Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00259766 Org: User:
Start: 04/30/04 End: 05/31/07 Due: 05/31/08

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02889900 Org: User:
Start: 01/17/17 End: 03/16/21 Due: 03/16/22

Exploratory Study to Assess the Pharmacokinetics of AZD5985

Phase: N/A Priority: Normal
NCT ID: NCT00799331 Org: User:
Start: 11/30/08 End: 02/28/09 Due: 02/28/10

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.

Phase: N/A Priority: Normal
NCT ID: NCT02174731 Org: User:
Start: 07/01/14 End: 09/26/18 Due: 09/26/19

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01323790 Org: User:
Start: 03/31/11 End: 09/30/12 Due: 09/30/13

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06112379 Org: User:
Start: 11/14/23 End: 11/03/32 Due: 11/03/33

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

Phase: N/A Priority: Normal
NCT ID: NCT00163501 Org: User:
Start: 12/31/03 End: 04/30/05 Due: 04/30/06

Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01276262 Org: User:
Start: 03/31/11 End: 11/30/11 Due: 11/30/12

AZD2624 Multiple Ascending Dose Study in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00696865 Org: User:
Start: 05/31/08 End: 08/31/08 Due: 08/31/09

A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00920608 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10